AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company specializing in the development of targeted, nonsystemic therapies for gastrointestinal (“GI”) diseases, has announced the completion of enrollment for its phase 2b OPTION 2 clinical trial to…
The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products sold under the brand names Alkaline88(r), A88 Infused(TM), and A88CBD(TM), will be participating at the 33rdannual…
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, has announced the release of its shelf registration feature. This new addition to SRAX’s software-as-a-service (“SaaS”) platform, Sequire, combines…
Mohawk Group (NASDAQ: MWK) enters a new product category with its latest acquisition of Healing Solutions LLC, a leading online seller of essential oils. Mohawk, a rapidly growing technology-enabled consumer products company, is on a…
CNS Pharmaceuticals (NASDAQ: CNSP) CEO John Climaco will be presenting at the inaugural Emerging Growth Virtual Conference. Scheduled for March 17–18, the virtual conference is presented by M Vest LLC and Maxim Group LLC. The…
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables and specialty testing services for the worldwide life sciences and other industries, was featured on a…
Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D metal printing industry, announced that it has been awarded a contract by Lockheed Martin Space Additive Design & Manufacturing Center.…
Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced that its Chief Executive Officer, Doug Drysdale, will be presenting a business and pipeline update at the M Vest and…
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) was featured in the The Bell2Bell Podcast, a part of InvestorBrandNetwork’s (“IBN”) sustained effort to provide specialized content distribution via widespread syndication channels. XPhyto Therapeutics’ CEO and…
RIV Capital (TSX: RIV) (OTC: CNPOF), (formerly Canopy Rivers Inc.), today announced that the asset purchase agreement proposed by PharmHouse Inc. has been approved by the Ontario Superior Court. The agreement outlines PharmHouse’s intent to…
PlantX Life (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF), a multifaceted marketplace providing consumers all things plant based, has announced that its founder, Sean Dollinger, will be presenting at the Q1 Virtual Investor Summit. The three-day summit is…
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, today announced promising preclinical data for its PH10 drug candidate. The data demonstrate that the…
Net Element (NASDAQ: NETE) is in the process of transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through a pending merger with privately-held Mullen Technologies Inc. Mullen today announced that it…
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, today announced that Brock Pierce, the entrepreneur, philanthropist and 2020 presidential candidate, has joined its board of directors. According…
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has published an update regarding its recent regulatory filing with the U.S. Securities & Exchange Commission (“SEC”) and announced a target…
Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its Chief Executive Officer, Doug Drysdale, will be presenting a business and pipeline update at the Stifel GMP Health…
iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China and a member of Oracle PartnerNetwork (“OPN”) is working with Oracle to develop a powerful tailored SaaS offering that empowers companies…
CNS Pharmaceuticals (NASDAQ: CNSP) CEO John Climaco, in a recent podcast, showed his excitement at news that the U.S. Food and Drug Administration (“FDA”) had granted Berubicin investigational new drug (“IND”) status. The IND designation…
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, has announced that its CEO James Sapirstein will present at the virtual Maxim Group Emerging Growth Virtual Conference. The two-day conference…
Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading producer of uranium and critical minerals in the United States, today announced that the first shipments of natural monazite ore arrived this past weekend at the…